| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05382728 | Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell… | NSCLC | Recruiting |
| Phase 2 | |||
| NCT05948813 | TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases | NSCLC | Recruiting |
| NCT06672068 | A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated… | NSCLC | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06950086 | Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors | HR-positive, HER2-negative Advanced Breast Cancer | Recruiting |
| NCT07104617 | Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic… | Metastatic Castration-resistant Prostate Cancer (mCRPC) | Not Yet Recruiting |
| NCT07104643 | Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic… | mCRPC | Not Yet Recruiting |
| NCT07282873 | Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors | Solid Tumor Malignancies | Not Yet Recruiting |
| Phase 1 | |||
| NCT05866692 | A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors | Solid Tumor, Adult | Recruiting |
| NCT06246071 | A Study of TYK-00540 in Adult Patients With Solid Tumors | Locally Advanced or Metastatic Solid Tumors | Recruiting |